Evidence map›Paper›PMID 41373965›Full record

ReviewNutrients2025

Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation.

Renāte Teterovska, Rūta Elvīra Skotele, Baiba Maurina, Inga Sile

Abstract readReview
In one paragraph

Review in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Plants (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Renāte TeterovskaDepartment of Pharmacology and Pharmacotherapy, Riga Stradinš University, 16 Dzirciema Street, LV-1007 Riga, Latvia.
Rūta Elvīra SkoteleDepartment of Pharmacology and Pharmacotherapy, Riga Stradinš University, 16 Dzirciema Street, LV-1007 Riga, Latvia.
Baiba MaurinaDepartment of Applied Pharmacy, Riga Stradinš University, 16 Dzirciema Street, LV-1007 Riga, Latvia.ORCID 0000-0001-9188-5681
Inga SileDepartment of Applied Pharmacy, Riga Stradinš University, 16 Dzirciema Street, LV-1007 Riga, Latvia.ORCID 0000-0002-8338-4964

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastrointestinal (GI) disorders associated with increased gastric acid secretion, such as gastroesophageal reflux, dyspepsia, bloating, and abdominal pain, significantly impair quality of life and present a substantial healthcare burden. Conventional therapies may have limited efficacy or undesirable side effects, underscoring the need for safe complementary approaches. This study systematically identifies and reviews the medicinal plants used in food supplements (FSs) marketed in Latvia for digestive health, focusing on the conditions linked to excess gastric acid.

methodsA structured literature search was conducted to identify European plant species with proven protective effects on the digestive system or the ability to influence gastric acid levels. A market analysis was performed using the Latvian Food and Veterinary Service FS Register.

resultsA total of 218 FS-containing medicinal plants were identified, of which 15 species were included in at least ten products. The most frequently used plants were peppermint (

conclusionsThis work contributes to the critical evaluation of plant-based FSs for digestive health, emphasizing the need for standardized preparations, harmonized health claim assessment, and further clinical research to establish efficacy and safety.

Indexed as

Dietary SupplementsGastric AcidGastrointestinal DiseasesPlants, MedicinalHumansfood supplementsgastric acidgastrointestinal disordershealth claimsmedicinal plants

Identifiers

PMID41373965
PMCPMC12693992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.